American Society of Clinical Oncology

SHERPA: White

People

  1. Kris
    Kris
  2. Rusch
    Rusch
  3. Downey
    Downey
  4. Heelan
    Heelan
  5. Miller
    Miller
  6. Schwartz
    Schwartz
  7. Seshan
    Seshan
  8. Bains
    Bains
  9. Chaft
    Chaft
  10. Ladanyi
    Ladanyi

Groups

  1. Department of Medicine (6)
  2. Solid Tumor Oncology Division (6)
  3. Surgery (6)
  4. Thoracic Oncology (6)
  5. Biostatistics Service (3)
  6. Epidemiology and Biostatistics (3)
  7. Body Imaging Service (2)
  8. Center for Pancreatic Cancer Research (2)
  9. Radiology, Department of (2)
  10. GSK Faculty (1)
Search Within
  1. "Thoracic Oncology"
  2. "Naiyer Rizvi"
  3. "Valerie Rusch"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (1)
Groups
  1. Department of Medicine (6)
  2. Solid Tumor Oncology Division (6)
  3. Surgery (6)
  4. Thoracic Oncology (6)
  5. Biostatistics Service (3)
  6. Epidemiology and Biostatistics (3)

More Groups

People
  1. Mark Kris (6)
  2. Naiyer Rizvi (6)
  3. Valerie Rusch (6)
  4. Christopher Azzoli (3)
  5. Lee Krug (3)
  6. Binsheng Zhao (2)

More People

Years
  1. 2012 (1)
  2. 2009 (2)
  3. 2007 (1)
  4. 2006 (1)
  5. 2004 (1)
Publications
  1. Journal of Clinical Oncology (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Quantitating pathologic response to neoadjuvant chemotherapy in KRAS-mutated versus nonmutated lung cancers
    Meeting Abstract

    Chaft, J. E.; Paik, P. K.; Sima, C. S.; Kris, M. G.; Krug, L. M.; Azzoli, C. G.; Riely, G. J.; Pietanza, M. C.; Rusch, V. W.; Travis, W. D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II study of induction and adjuvant bevacizumab in patients with stage IB-IIIA non-small cell lung cancer (NSCLC) receiving induction docetaxel and cisplatin
    Meeting Abstract

    Price, K.; Kris, M. G.; Rusch, V.; Finley, D. J.; Azzoli, C. G.; Downey, R. J.; Bains, M. S.; Miller, V. A.; Rizk, N.; Rizvi, N. A.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Operative outcomes using bevacizumab, docetaxel, and cisplatin as induction therapy in patients with operable lung cancer
    Meeting Abstract

    Finley, D. J.; Shen, R.; Rizvi, N. A.; Rusch, V. W.; Kris, M. G.; on behalf of the MSKCC Thoracic Disease Management Team
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Single agent bevacizumab and bevacizumab in combination with docetaxel and cisplatin as induction therapy for resectable IB-IIIA non-small cell lung cancer
    Meeting Abstract

    Rizvi, N. A.; Rusch, V.; Zhao, B.; Senturk, E.; Schwartz, L.; Fury, M.; Downey, R.; Rizk, N.; Krug, L.; Kris, M. G.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Prospective trial with preoperative gefitinib to correlate lung cancer response with EGFR exon 19 and 21 mutations and to select patients for adjuvant therapy
    Meeting Abstract

    Kris, M. G.; Pao, W.; Zakowski, M. F.; Ladanyi, M.; Heelan, R. T.; Schwartz, L.; Zhao, B.; Venkatraman, E.; Rusch, V.; Rizvi, N. A.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer
    Journal Article

    Miller, V. A.; Kris, M. G.; Shah, N.; Patel, J.; Azzoli, C.; Gomez, J.; Krug, L. M.; Pao, W.; Rizvi, N.; Pizzo, B.; more...
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save